memantine - CISMeF

Preferred Label : memantine;

MeSH definition : AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.;

MeSH synonym : 1,3-dimethyl-5-aminoadamantane; 1-amino-3,5-dimethyladamantane; memantin;

CISMeF synonym : lundbeck brand of memantine hydrochloride; merz brand of memantine hydrochloride;

CISMeF acronym : D145;

DeCS synonym : D145;

MeSH hyponym : memantine hydrochloride; axura; D-145; Ebixa; namenda; D 145; D145;

MeSH CAS label : Tricyclo(3.3.1.13,7)decan-1-amine, 3,5-dimethyl-;

MeSH Related Number : 19982-08-2 (Memantine); memantine hydrochloride; JY0WD0UA60;

Registry Number MeSH : 19982-08-2;

Related CAS MeSH : JY0WD0UA60 (Memantine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Memantine;

Is substance : O;

UNII : W8O17SJF3T;

InChIKey : BUGYDGFZZOZRHP-UHFFFAOYSA-N;

Details

Origin ID

D008559;

UMLS CUI

C0025242;

ATC code(s)
- donepezil and memantine [ATC Code]
- donepezil, memantine and Ginkgo folium [ATC Code]
- memantine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Namenda [ICHI extension code]
CISMeF manual mappings
- Memantine (substance) [SNOMED CT concept]
- memantine [Substance BNPC]
Pharmacological action(s)
- antiparkinson agents [MeSH Descriptor]
- dopamine agents [MeSH Descriptor]
- excitatory amino acid antagonists [MeSH Descriptor]
Record concept(s)
- D-145 [MeSH concept]
- Ebixa [MeSH concept]
- axura [MeSH concept]
- memantine [MeSH concept]
- memantine hydrochloride [MeSH concept]
- namenda [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-amino-3-fluoromethyl-5-methyladamantane [MeSH Supplementary Concept]
- ARN14140 [MeSH Supplementary Concept]
- Namzaric [MeSH Supplementary Concept]
- fluoroethylnormemantine [MeSH Supplementary Concept]
- lipoyl-memantine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Memantine [LOINC component]
- Memantine [ICD-11 Extension code]
- Memantine [NCIt concept]
- Memantine (substance) [SNOMED CT concept]
- Product containing memantine (medicinal product) [SNOMED CT concept]
- memantine [ATC Code]
- memantine [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients